BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 30481753)

  • 1. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth.
    Pihoker C; Gilliam LK; Ellard S; Dabelea D; Davis C; Dolan LM; Greenbaum CJ; Imperatore G; Lawrence JM; Marcovina SM; Mayer-Davis E; Rodriguez BL; Steck AK; Williams DE; Hattersley AT;
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4055-62. PubMed ID: 23771925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus.
    Yorifuji T; Fujimaru R; Hosokawa Y; Tamagawa N; Shiozaki M; Aizu K; Jinno K; Maruo Y; Nagasaka H; Tajima T; Kobayashi K; Urakami T
    Pediatr Diabetes; 2012 Feb; 13(1):26-32. PubMed ID: 22060211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive screening for monogenic diabetes in 89 Japanese children with insulin-requiring antibody-negative type 1 diabetes.
    Ushijima K; Fukami M; Ayabe T; Narumi S; Okuno M; Nakamura A; Takahashi T; Ihara K; Ohkubo K; Tachikawa E; Nakayama S; Arai J; Kikuchi N; Kikuchi T; Kawamura T; Urakami T; Hata K; Nakabayashi K; Matsubara Y; Amemiya S; Ogata T; Yokota I; Sugihara S;
    Pediatr Diabetes; 2018 Mar; 19(2):243-250. PubMed ID: 28597946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.
    Warncke K; Kummer S; Raile K; Grulich-Henn J; Woelfle J; Steichen E; Prinz N; Holl RW
    J Clin Endocrinol Metab; 2019 Mar; 104(3):845-855. PubMed ID: 30535056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturity-onset diabetes of the young (MODY): an update.
    Anık A; Çatlı G; Abacı A; Böber E
    J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):251-63. PubMed ID: 25581748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns.
    Bonnycastle LL; Willer CJ; Conneely KN; Jackson AU; Burrill CP; Watanabe RM; Chines PS; Narisu N; Scott LJ; Enloe ST; Swift AJ; Duren WL; Stringham HM; Erdos MR; Riebow NL; Buchanan TA; Valle TT; Tuomilehto J; Bergman RN; Mohlke KL; Boehnke M; Collins FS
    Diabetes; 2006 Sep; 55(9):2534-40. PubMed ID: 16936201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
    McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
    Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.
    Schober E; Rami B; Grabert M; Thon A; Kapellen T; Reinehr T; Holl RW;
    Diabet Med; 2009 May; 26(5):466-73. PubMed ID: 19646184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
    López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
    Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
    Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O
    Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.